Li Yu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors (NCT04292769) | Li Yu | 2020-01-21 |
Track Li Yu automatically
Every clearance here is in the API, with alerts when new ones post.